The UCLA TMS Clinical and Research Service

Treatment with TMS at UCLA is administered by the TMS Treatment Service. Our physicians are Board-Certified Psychiatrists and full-time professors of Psychiatry at UCLA, each with years of experience in the treatment of depression and other complex mood disorders and with specific training in neuromodulation techniques. We are ably assisted by other members of our treatment team, who come from diverse backgrounds including nursing and psychology. Our team at UCLA was the first service within the University of California system to offer TMS treatment to patients.

Individuals who are seeking care with TMS at UCLA are initially evaluated by one of the physicians on our team, Drs. Leuchter, Krantz, Levitt, Minzenberg, Ginder, Dunn, or Jalil. The objective of this consultation is to get to know a prospective individual patient's clinical situation, how their mood disorder has impacted their life, what treatments may have been tried before (and what the outcomes were), and any medical issues that may bear on the safe administration of TMS. We seek to ensure the highest quality of care for individuals with depression, whether that means treatment with TMS or whether we may recommend some other alternative.

All treatment planning and stimulation sessions are conducted by our Psychiatrists.

Treatments are administered in our state-of-the-art Neuromodulation Suite in the Semel Institute (Neuropsychiatric Institute) Building, 760 Westwood Blvd, Los Angeles, on the UCLA Campus (map, directions). For TMS treatments in depression, we employ FDA-approved systems for therapeutic TMS, Magtsim and MagVenture.

Andrew Leuchter, M.D.

Andrew F. Leuchter, MD, is a Professor in the Department of Psychiatry and Biobehavioral Science, Director of the Neuromodulation Division, and a Senior Research Scientist at the Semel Institute for Neuroscience and Human Behavior at UCLA. A graduate of Stanford University, Dr. Leuchter earned his medical degree from Baylor College of Medicine in Houston, Texas. He joined the UCLA faculty in 1986.

An internationally recognized expert on the treatment of mood disorders, Dr. Leuchter’s research focuses on the enhancement of treatment outcomes in depression. He directs the Transcranial Magnetic Stimulation (TMS) Service in the Division, which performs more than 2,500 treatments each year for patients with depression, pain, and other neuropsychiatric illness. He is leading clinical trials to develop novel neuromodulation technologies for treatment of depression and Post-Traumatic Stress Disorder (PTSD), including synchronized Transcranial Magnetic Stimulation (sTMS) and Trigeminal Nerve Stimulation (TNS). He uses brain-imaging techniques, such as quantitative electroencephalography (qEEG), magnetic resonance imaging (MRI), and positron emission tomography (PET), to examine brain function and predict which treatments are most likely to benefit individual patients. Dr. Leuchter’s research program combines clinical trials with neurophysiologic and brain-imaging studies to inform clinical practice in the treatment of depression. As a Board certified electroencephalographer, he has unique expertise in development of biomarkers and has shown that brain oscillation patterns can be used to determine highly beneficial and individualized treatment.

Dr. Leuchter is a Diplomat of the American Board of Electroencephalography and Neurophysiology and a Diplomat in Psychiatry and Neurology with Added Qualifications in Geriatric Psychiatry. He is a member of several professional organizations, including the American Psychiatric Association, American Psychiatric Electrophysiology Association, and the American Medical EEG Association. He has authored over 150 scientific articles on topics including neuromodulation for the treatment of depression, biomarkers to guide treatment of neuropsychiatric illness, and theories of antidepressant action. He also maintains an active clinical practice, specializing in consultation for and care of patients suffering from treatment-resistant depression.

For more information on Dr. Leuchter, please visit: www.andrewleuchter.com

David Krantz, M.D., Ph.D.

David Krantz is a Professor in Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA.

An undergraduate at Brown University, he completed an MD/PhD in the Medical Scientist Training Program at UCLA in 1991, where he performed his dissertation on Drosophila eye development with Larry Zipursky. After a residency in psychiatry at UCLA, he was awarded a Howard Hughes Postdoctoral Fellowship for Physicians to investigate the regulation of vesicular neurotransmitter transporters in Robert Edwards' laboratory at UCSF.

He returned to UCLA in 2000, and is currently using Drosophila to study how changes in the function of neurotransmitter transporters may influence synaptic transmission and behavior.

UCLA Committees:

  • Neuroscience IDP Dissertation Committee (2002-ongoing; Chair, 2005-ongoing)
  • Neuroscience IDP Vice Chair (2007-2010)
  • Psychiatry Residency Research Track Oversight Committee (2003-ongoing; Chair, 2006-ongoing)
  • Medical Scientist Training Program Admissions Committee (2002-2007)
  • Neuroscience Seminar Speaker Selection Committee (2003-2013)

Jennifer G. Levitt, M.D.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 1993

Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology, 1994

Fellowship:

Psychiatry, Stanford University School of Medicine, 1990-1991

Residency:

Psychiatry, Stanford University School of Medicine, 1987-1990

Child Psychiatry, UCLA Neuropsychiatric Hospital, 1991-1993

Internship:

Internal Medicine, University of North Carolina Hospitals, 1986-1987

Degree:

University of North Carolina, Chapel Hill, School of Medicine, MD, 1986

Jonathan Lee, M.D.

Jonathan Lee is a child and adolescent psychiatrist and fellow of the Royal College of Physicians and Surgeons of Canada. He completed his master’s thesis with Dr. Jeff Daskalakis at the Temerty Centre for Therapeutic Brain Intervention where he studied the clinical and neurophysiological effects of theta-burst stimulation in depressed youth. His research aims to expand treatment options for youth with neuropsychiatric conditions.

Medical Board Certifications:

Psychiatry, Royal College of Physicians and Surgeons of Canada, 2015

Child and Adolescent Psychiatry, Royal College of Physicians and Surgeons of Canada, 2016

Fellowship:

Brain Stimulation/Child and Adolescent Psychiatry, Centre for Addiction and Mental Health, Temerty Centre for Therapeutic Brain Intervention

Residency:

Psychiatry, University of Toronto, 2010-2015

Child and Adolescent Psychiatry, University of Toronto, 2015-2016

Internship:

Queen’s University, 2008-2010

Degree:

Queen’s University, School of Medicine, MD, 2010

Institute of Medical Science, MS, 2018

Nathaniel Ginder, M.D., Ph.D.

Nathaniel Ginder, MD, PhD, is fellowship trained in Child and Adolescent Psychiatry. He has interests in applications of TMS for children and adolescents as well as its application in addictive behaviors.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2015

Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology, 2017

Fellowship:

Child and Adolescent Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, 2015-2018

Residency:

Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, 2013-2015

Internship:

Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, 2012-2013

Degrees:

Washington University in St. Louis, School of Medicine, MD, 2012

Iowa State University, PhD, Biochemistry, 2008

Reza Tadayon-Nejad, M.D., Ph.D.

Dr. Tadayon-Nejad is an Assistant Clinical Professor of Psychiatry at UCLA and Visiting Associate faculty in Neuroscience at California Institute of Technology.

His clinical focus is on treatment of refractory depression, OCD and comorbid OCD-Depression by using multimodal treatment options of Transcranial Magnetic Stimulation (TMS), advanced pharmacology and Exposure and Response Prevention therapy.

In collaboration with decision neuroscientists at Caltech, Dr. Tadayon-Nejad research explores the neurobehavioral and circuit mechanisms of abnormal decision-making in psychiatric disorders, particularly OCD, by using methods and concepts from computational neuroscience, neuroimaging (fMRI, DTI, EEG) and noninvasive neurostimulation (tDCS, TMS). His research is funded by NIMH and Brain & Behavior Research Foundation (NARSAD).

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2015

Fellowship:

NIMH funded T32 fellowship in neuroscience of mental health with focus on psychiatric neuroimaging (fMRI, DTI, EEG), University of Illinois at Chicago, 2014-2016

Residency:

Psychiatry, University of Illinois at Chicago, 2011-2015

Degrees:

University of Calgary, PhD, 2011

Ahwaz University of Medical Sciences, MD, 2004

Scott A. Wilke, M.D., Ph.D.

Dr. Wilke is an Assistant Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA and is a psychiatrist and neuroscientist. His research investigates the structure and function of neural circuits that underlie neuropsychiatric disorders. Dr. Wilke received his BS in neurobiology from the University of Washington and went on to earn his MD and PhD in neuroscience in the Medical Scientist Training Program at UC San Diego. He completed his doctoral thesis with Dr. Anirvan Ghosh, studying activity-dependent mechanisms regulating the assembly of hippocampal circuits in the developing brain. He went on to complete a residency in adult psychiatry and to do his postdoctoral research at UC San Francisco with Dr. Vikaas Sohal. The Wilke laboratory studies the prefrontal cortex, using molecular genetic tools to observe and alter activity in the brain during behavior. Ultimately his work seeks to understand the development and resolution of depressed states at the level of specific neural circuits. You can learn more about his research at www.wd2labs.org/wilke-lab.

Dr. Wilke is also an active clinician with expertise in interventional approaches to treat psychiatric conditions by modulating activity in the brain. He is an attending physician in the Neuromodulation Division of the Semel Institute for Neuroscience and Human Behavior and specializes in transcranial magnetic stimulation (TMS) to treat refractory depression.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2016

Fellowship:

Research Fellowship, UCSF School of Medicine, 2016-2018

Residency:

Psychiatry, UCSF School of Medicine, 2012-2016

Degrees:

UCSD School of Medicine, MD, PhD, 2012

Walter Dunn, M.D., Ph.D.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2014

Residency:

Psychiatry, UCLA Neuropsychiatric Hospital, 2011-2014

Internship:

Psychiatry, UCLA Neuropsychiatric Hospital, 2010-2011

Degree:

UC Davis, MD, 2010

UC Berkeley, PhD, 2005

Jason Jalil, M.D.

Medical Board Certifications:

Psychiatry, American Board of Psychiatry and Neurology, 2016

Fellowship:

Geriatric Psychiatry, UCLA School of Medicine, 2016-2017

Residency:

Psychiatry, UCLA School of Medicine, 2013-2016

Internship:

Psychiatry, UCLA School of Medicine, 2012-2013

Degree:

Sackler School of Medicine, MD, 2012

Staff

Name

Role

Joel Diaz TMS & EEG Technician
Michelle Abrams, RN Nurse
Nikita Vince-Cruz Research Manager
Jola Leskinen TMS Scheduling Coordinator
Alex Afewerki TMS Technician
Jenna Kantor TMS Technician
Doan Ngo TMS Technician
Kristine Reina TMS Intake Coordinator